Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.455 AUD | -3.64% | -9.63% | +73.21% |
Mar. 26 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
Mar. 18 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Tillett
CEO | Chief Executive Officer | - | Nov. 21 |
Chief Tech/Sci/R&D Officer | - | 23-06-30 | |
Tim Hammond
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-22 |
Michael Kelso
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Chief Tech/Sci/R&D Officer | - | 20-02-29 | |
Phillip Lynch
BRD | Director/Board Member | - | 20-05-31 |
Sophia Moscovis
PRN | Corporate Officer/Principal | - | - |
Borje Andersson
PRN | Corporate Officer/Principal | - | 20-01-31 |
Peter Webse
SEC | Corporate Secretary | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Smith
BRD | Director/Board Member | 61 | 23-06-28 |
Borje Andersson
PRN | Corporate Officer/Principal | - | 20-01-31 |
Phillip Lynch
BRD | Director/Board Member | - | 20-05-31 |
Mary Harney
CHM | Chairman | - | 21-02-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 163,496,251 | 122,094,853 ( 74.68 %) | 0 | 74.68 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+73.21% | 168M | |
+11.15% | 115B | |
+12.83% | 106B | |
-4.60% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.79% | 17.56B | |
-40.50% | 17.32B | |
+7.29% | 14.03B | |
+33.00% | 12.13B |
- Stock Market
- Equities
- RAC Stock
- Company Race Oncology Limited